Ambien vs Lunesta: Differences, Effectiveness, Side Effects, and Safety
Compare Ambien vs Lunesta, including active ingredients, sleep benefits, side effects, duration, and important prescript
Ambien vs Lunesta
Sleep difficulties can affect concentration, mood, energy, and everyday activities. Two prescription medicines commonly discussed for insomnia are zolpidem, sold as Ambien, and eszopiclone, sold as Lunesta. Understanding the differences between them can help patients have a more informed discussion with a healthcare professional.
Ambien vs Lunesta is a comparison of two sedative-hypnotic medicines, but neither option is appropriate for everyone. Treatment depends on the type of sleep difficulty, medical history, other medications, and individual response.
Ambien contains zolpidem. In the United States, immediate-release Ambien is approved for short-term treatment of insomnia characterized by difficulty falling asleep. Other zolpidem formulations have different indications, so the formulation matters when discussing treatment.
Possible adverse effects include dizziness, drowsiness, impaired coordination, and reduced alertness the following day.
Lunesta contains eszopiclone and is prescribed for insomnia. Depending on the patient and clinical circumstances, sleep difficulties may involve trouble falling asleep, staying asleep, or both.
Potential side effects include an unpleasant taste, dry mouth, dizziness, and drowsiness. Individual experiences vary, and side effects should be discussed with the prescribing clinician.
FeatureAmbienLunestaActive ingredientZolpidemEszopicloneMedication classSedative-hypnoticSedative-hypnoticSleep concernsFormulation-dependent; immediate-release treats sleep-onset difficultyInsomnia, including difficulty falling or staying asleepPossible side effectsDrowsiness, dizziness, impaired coordinationUnpleasant taste, dry mouth, dizziness, drowsinessSerious safety concernComplex sleep behaviorsComplex sleep behaviors
Neither medicine should be considered universally more effective or safer. A clinician should evaluate the specific sleep problem and potential risks.
The U.S. Food and Drug Administration (FDA) warns that zolpidem and eszopiclone can cause complex sleep behaviors, including sleepwalking and sleep-driving, sometimes resulting in serious injury or death. If one occurs, stop taking the medicine and contact a healthcare professional immediately.
Avoid alcohol and do not combine sleep medicines or other sedatives without medical guidance. Take medication only as prescribed and allow the required time for sleep.
For chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) is an evidence-based treatment recommended by the American Academy of Sleep Medicine. A clinician may also assess pain, stress, irregular schedules, or other conditions contributing to poor sleep.
Ambien and Lunesta have different active ingredients and side-effect profiles, even though both are used to treat insomnia. The right treatment depends on individual circumstances, not simply on which medicine appears stronger or lasts longer.
Medical disclaimer: This article is for educational purposes only and does not replace individualized medical advice. Consult a qualified healthcare professional before starting, stopping, or changing sleep medication.
Editorial references: FDA information on prescription insomnia medicines · FDA boxed warning on complex sleep behaviors